Larvol Delta - CNS-Pharmaceuticals-Expands-Pipeline-with-In-License-of-Late-Stage-Novel-Potential-Blood-Brain-Barrier-Permeable-Abeotaxane-for-Treatment-of-Brain-Malignancies

TPI 287 - CNS Pharma

https://cnspharma.com/ir/press-releases/cns-pharmaceuticals-expands-pipeline-with-in-license-of-late-stage-novel-potential-blood-brain-barrier-permeable-abeotaxane-for-treatment-of-brain-malignancies-40033084

Jul 30, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next